Should we be cautious on the use of commercially available antibodies to dopamine receptors?

Serena Bodei, Nicola Arrighi, Pierfranco Spano, Sandra Sigala

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Should we be cautious on the use of commercially available antibodies to dopamine receptors?'. Together they form a unique fingerprint.

Medicine & Life Sciences